`
` Volume 4
`
` Pages 615 - 831
`
`UNITED STATES DISTRICT COURT
`
`NORTHERN DISTRICT OF CALIFORNIA
`
`BEFORE THE HONORABLE WILLIAM H. ALSUP, JUDGE
`
`)
`FINJAN, INC.,
` )
` Plaintiff, )
` )
` VS. ) No. C 17-5659 WHA
` )
`JUNIPER NETWORKS, INC.,
`)
` )
` Defendant.
`)
` ) San Francisco, California
` Thursday, December 13, 2018
`
`
`TRANSCRIPT OF PROCEEDINGS
`
`
`APPEARANCES:
`
`For Plaintiff: KRAMER, LEVIN, NAFTALIS & FRANKEL LLP
` 990 Marsh Road
` Menlo Park, California 94025
` BY: PAUL J. ANDRE, ESQ.
` LISA KOBIALKA, ESQ.
` JAMES HANNAH, ESQ.
` KRISTOPHER B. KASTENS, ESQ.
`
` KRAMER LEVIN NAFTALIS AND FRANKEL LLP
` 1177 Avenue of the Americas
` New York, New York 10036
` BY: CRISTINA LYNN MARTINEZ, ESQ.
`
`
`(Appearances continued on next page)
`
`
`
`
`Reported By: Katherine Powell Sullivan, CSR No. 5812, RMR, CRR
` Jo Ann Bryce, CSR No. 3321, RMR, CRR
` Official Reporters
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 2 of 218
`
`APPEARANCES (CONTINUED):
`
`For Defendant: IRELL & MANELLA LLP
` 1800 Avenue of the Stars, Suite 900
` Los Angeles, California 90067-4276
` BY: JONATHAN S. KAGAN, ESQ.
` ALAN J. HEINRICH, ESQ.
` JOSHUA GLUCOFT, ESQ.
` CASEY CURRAN, ESQ.
`
` IRELL & MANELLA LLP
` 840 Newport Center Drive, Suite 400
` Newport Beach, California 92660
` BY: REBECCA CARSON, ESQ.
` KEVIN X. WANG, ESQ.
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 3 of 218
`
`I N D E X
`
`642
`
`643
`
`
`Thursday, December 13, 2018 - Volume 4
`
` PAGE VOL.
`Plaintiff Rests
`643
`4
`
`PLAINTIFF'S WITNESSES PAGE VOL.
`
`ICASIANO, ALEX
`By Videotaped Deposition
`
`GUPTA, SHELLY
`By Videotaped Deposition
`
`DEFENDANT'S WITNESSES PAGE VOL.
`
`BUSHONG, MICHAEL
`(SWORN)
`Direct Examination by Ms. Carson
`Cross-Examination by Mr. Hannah
`Redirect Examination by Ms. Carson
`
`RUBIN, AVIEL
`(SWORN)
`Direct Examination by Mr. Heinrich
`Cross-Examination by Mr. Andre
`Redirect Examination by Mr. Heinrich
`
`UGONE, KEITH RAYMOND
`(SWORN)
`Direct Examination by Ms. Curran
`Cross-Examination by Ms. Kobialka
`
`644
`645
`698
`709
`
`4
`
`4
`
`4
`4
`4
`4
`
`4
`4
`4
`4
`
`4
`4
`4
`
`710
`711
`771
`796
`
`797
`798
`820
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 4 of 218
`
`I N D E X
`
` E X H I B I T S
`
`
`TRIAL EXHIBITS IDEN EVID VOL.
`
`58
`
`182
`
`1059
`
`1070
`
`1170
`
`1241, Title Page & Table of Contents
`
`1241, Page 39
`
`1248
`
`1264
`
`1347
`
`1552
`
`2197
`
`
`763
`
`685
`
`686
`
`727
`
`720
`
`690
`
`730
`
`760
`
`751
`
`682
`
`726
`
`724
`
`4
`
`4
`
`4
`
`4
`
`4
`
`4
`
`4
`
`4
`
`4
`
`4
`
`4
`
`4
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 5 of 218
`
`PROCEEDINGS
`
` 619
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Thursday - December 13, 2018
`
` 7:25 a.m.
`
`P R O C E E D I N G S
`
`(The following proceedings were held in open court,
`
`outside the presence of the jury:)
`
`THE COURT: Okay. What can I do for the lawyers?
`
`MR. ANDRE: A couple of things, Your Honor. One is, I
`
`hesitate to mention this, but I need the time. There is a
`
`10-minute error in your calculation.
`
`THE COURT: You're right. Tana told me that
`
`yesterday. You have 10 extra minutes. I added it up wrong.
`
`You have 10 more minutes than I had thought.
`
`MR. ANDRE: That's golden for me right now.
`
`THE COURT: It is. Okay.
`
`MR. ANDRE: Second thing, this is a procedural issue
`
`as well. We're in the process of going through a redaction
`
`process of the transcript of the phone call.
`
`We got the proposed redactions last night. We have some
`
`objections to the redactions. We can email you the copies or I
`
`have hard copies here you can take with you. I just -- my
`
`handwritten notes are on it.
`
`THE COURT: Redactions of the phone call?
`
`MR. ANDRE: Yeah. About the joint defense --
`
`THE COURT: It's all blacked out. I won't be able to
`
`tell what it is.
`
`MR. ANDRE: We have the unredacted version along with
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 6 of 218
`
`PROCEEDINGS
`
` 620
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`the redacted version.
`
`THE COURT: Can you just tag the parts that you care
`
`about?
`
`MR. ANDRE: We did. It doesn't have to be today, Your
`
`Honor, because --
`
`THE COURT: Well, it might have to be today. Give it
`
`to me now, and I'll see what I can do.
`
`MR. ANDRE: This is the copy that will go back to the
`
`jury room. So I'm pretty sure that won't happen at least until
`
`tomorrow and probably possibly even Monday.
`
`THE COURT: All right. What else?
`
`MR. ANDRE: I believe Ms. Martinez has an issue about
`
`noninfringing alternatives.
`
`MS. MARTINEZ: Good morning, Your Honor. We just have
`
`an issue with some slides that were disclosed by Juniper for
`
`Dr. Ugone and Dr. Rubin. They have information about
`
`noninfringing alternatives, which we understood were withdrawn.
`
`THE COURT: That's right.
`
`MS. MARTINEZ: And I believe, Your Honor --
`
`THE COURT: I thought you said that that wouldn't be
`
`in the case.
`
`MS. CURRAN: I think they're confusing the issue, Your
`
`Honor.
`
`As to Dr. Cole's noninfringing alternative, we filed a MIL
`
`at the pretrial conference. My colleague, Ms. Carson, said we
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 7 of 218
`
`PROCEEDINGS
`
` 621
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`didn't need to get into it as long as they didn't plan to
`
`introduce that testimony to him.
`
`As to Juniper's noninfringing alternatives, your Daubert
`
`order expressly found that the disclosure of noninfringing
`
`alternatives was timely. I have that here. I can pass it up
`
`to you, if you like.
`
`THE COURT: You said at the final pretrial conference
`
`that if I excluded it to them, it would no longer be an issue
`
`in the case. Now you're using some slick maneuver to say they
`
`don't get to use it, but you get to use it.
`
`What is it even relevant to?
`
`MS. CURRAN: We think it's relevant to the
`
`hypothetical negotiation here, right, would be constrained on
`
`the amount Juniper would be willing to pay at the time of the
`
`hypothetical negotiation, given they could design around the
`
`patent.
`
`THE COURT: Yeah, but they wanted to put it in for
`
`that purpose; right? I think. I don't know. Seems like that
`
`was part of their purpose.
`
`MS. CURRAN: Part of their purpose for their
`
`noninfringing alternative right was to show their cost savings
`
`theory, but the cost savings theory had serious flaws. That's
`
`why it was excluded by your opinion.
`
`Their only objection to our noninfringing alternative --
`
`THE COURT: All right. Here is the answer. Here is
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 8 of 218
`
`PROCEEDINGS
`
` 622
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`the answer. If your side puts in anything on noninfringing
`
`alternatives for that purpose, then I will give you extra time.
`
`I will let you reopen your direct, your case, and you can put
`
`in rebuttal information on noninfringing alternatives.
`
`If you want to open that door, God bless you, you can.
`
`But I'm telling you I feel I got flimflammed by Juniper on
`
`this. You pulled a slick maneuver.
`
`All right. That's going to be the ruling. So if you want
`
`to go down that path, then they're going to get to have a
`
`little bit of rebuttal on that. And you won't even -- and
`
`they're just going -- it's going to be freewheeling. They get
`
`to put their guy back up there and go to town on noninfringing
`
`alternatives.
`
`All right. What else do you have?
`
`MR. KAGAN: Your Honor, we would --
`
`THE COURT: I don't know why the lawyers would want to
`
`get me that upset. I'm not upset. But why would you do that
`
`to me? Why do the lawyers -- okay. I'm just thinking out
`
`loud.
`
`All right. What's your next point?
`
`MR. KAGAN: Your Honor, we have one minor issue.
`
`Mr. Garland testified yesterday in plaintiff's case-in-chief.
`
`We're going to recall him --
`
`THE COURT: Yes, you are.
`
`MR. KAGAN: -- in our case-in-chief because there was
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 9 of 218
`
`PROCEEDINGS
`
` 623
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`an objection to beyond the scope.
`
`We believe, when we look through the testimony, we can
`
`actually just present Mr. Garland's testimony. We have about
`
`one minute of deposition testimony which we could just present.
`
`But we didn't designate it as deposition testimony.
`
`THE COURT: If there's an objection, you have to do it
`
`the hard way.
`
`Is there an objection?
`
`MR. ANDRE: I don't even know what it is, Your Honor.
`
`I saw an email come in last night at 11:00 o'clock to that
`
`nature. I have not had a chance to look at it.
`
`THE COURT: Is he here, out there in the hall cooling
`
`his heels?
`
`MR. ANDRE: I don't know if he's there just yet.
`
`He'll be here this morning. He canceled his flight, and he's
`
`here.
`
`THE COURT: Plan A is, he's going to be called live.
`
`Plan B, if you two agree, will be you can substitute the
`
`deposition. But I'm not going to say it's okay yet because,
`
`no, it wasn't designated.
`
`Anything else?
`
`MR. ANDRE: That's it, Your Honor. We're going to be
`
`playing a couple short depositions this morning, and then we'll
`
`close our case.
`
`THE COURT: All right. Do you have anything more?
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 10 of 218
`
`PROCEEDINGS
`
` 624
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Because I have something important I want to bring up with you.
`
`Do you have anything more?
`
`MR. KAGAN: No, Your Honor.
`
`MR. WANG: Your Honor, we actually do have objections
`
`to Finjan's invalidity expert's demonstratives, if we can
`
`address them.
`
`THE COURT: I thought the case was virtually over. Is
`
`this one of your -- what invalidity expert?
`
`MR. WANG: This is their rebuttal expert to the 101
`
`issues.
`
`THE COURT: Well, when is that going to be presented?
`
`MR. WANG: Right after our -- when we close our
`
`case-in-chief.
`
`THE COURT: You mean when the jury is deliberating or
`
`something?
`
`MR. ANDRE: Your Honor, they are intending to put
`
`forward a 101 defense with their expert, Dr. Rubin.
`
`THE COURT: Yeah.
`
`MR. ANDRE: We had put a rebuttal expert in. I
`
`thought that went away because of Your Honor's ruling. But
`
`they intend to do it, so Dr. Orso is sitting back there in the
`
`courtroom. He's been cooling his heels, waiting to go on the
`
`stand for rebuttal to Dr. Rubin's 101 issue.
`
`THE COURT: What if you run out of time?
`
`MR. ANDRE: We're going to be okay on time, Your
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 11 of 218
`
`PROCEEDINGS
`
` 625
`
`Honor. We do pretty quick crosses. We won't spend a lot of
`
`time.
`
`time?
`
`THE COURT: But on your direct, what if you run out of
`
`MR. ANDRE: We won't.
`
`THE COURT: All right. Well, is this when the jury is
`
`deliberating?
`
`MR. ANDRE: No, no.
`
`THE COURT: This is while the jury is here?
`
`MR. ANDRE: I guess.
`
`I thought this was going to be something you were going to
`
`take up outside the presence of the jury. And on a 101 issue,
`
`kind of like -- we'd mentioned Judge Freeman had done this.
`
`She had held a bench trial on 101 after the jury verdict came
`
`back. And we thought that's what you were going to do.
`
`But with Dr. Rubin, they've -- they've put --
`
`THE COURT: If the jury is going to hear it for them,
`
`they get to hear it for you if you still have time.
`
`All right. I don't want to go into those objections now.
`
`MR. WANG: Yes, Your Honor.
`
`THE COURT: We'll get to it in due course.
`
`Look, I want to give you a heads-up on -- and get an
`
`advance -- I want to focus now on the rule. I know you haven't
`
`closed your case out, but you're virtually there.
`
`And we have 20 minutes now, and I want to hear the Rule 50
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 12 of 218
`
`PROCEEDINGS
`
` 626
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`motion, or at least a preview of it, because I may grant it on
`
`the issue of damages.
`
`So who's going to argue that?
`
`MR. KAGAN: Your Honor, I can address the overview of
`
`the motion.
`
`THE COURT: All right. What is it going to be?
`
`MR. KAGAN: So there's a number of issues. One is
`
`there's no allocation --
`
`THE COURT: Apportionment.
`
`MR. KAGAN: -- apportionment between the infringing
`
`and noninfringing -- or the value of the infringing, alleged
`
`infringing technology to the overall benefit of the accused
`
`products.
`
`So there's two issues. One is, there is SRX. And second
`
`is, there's Sky ATP. So they need to say this portion of Sky
`
`ATP's sales or its success is attributable to the infringing --
`
`to the alleged infringement.
`
`They have to put on testimony, competent testimony, to
`
`indicate how they can apportion that. They have not done that.
`
`The same thing goes with SRX. And remember all the -- and
`
`this -- there's no question the SRX has noninfringing uses.
`
`99 percent of the SRXs sold are not even capable of being used
`
`with the Sky ATP software.
`
`THE COURT: Well, they would be if you flipped the
`
`switch. But isn't there a router function that's built in
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 13 of 218
`
`PROCEEDINGS
`
` 627
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`there too?
`
`MR. KAGAN: Yes, there is, Your Honor.
`
`THE COURT: And wasn't there a router before they ever
`
`had SRX? In other words, Juniper -- this is the most recent
`
`router, but they had routers before they had SRX.
`
`MR. KAGAN: That's correct, Your Honor. So the SRXs
`
`that are currently being sold -- so if somebody buys or uses
`
`for free that Sky ATP functionality, that doesn't mean that's
`
`the only thing they're using it for. They're also using that
`
`device that still has all the other functionality.
`
`So they need to get someone on the stand who can say, for
`
`example, X percentage of the value is due to Sky ATP
`
`functionality. And then they have to go even farther. What
`
`percentage of that Sky ATP functionality is due to the alleged
`
`infringement?
`
`THE COURT: All right. I just want to focus on that.
`
`I think that's a serious problem for the plaintiff. And
`
`I'd like to hear what you say to that on both of those two
`
`apportionment points.
`
`MR. ANDRE: Your Honor, you'll be hearing the
`
`deposition testimony of Alex Icasiano first thing this morning.
`
`THE COURT: Who is he?
`
`MR. ANDRE: He is the 30(b)(6) witness designated by
`
`Juniper to talk exactly about this point, the apportionment;
`
`what percentage of files the Sky ATP reviews, what percentage
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 14 of 218
`
`PROCEEDINGS
`
` 628
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`goes through the infringing functionality of being scanned
`
`dynamically.
`
`Now, the Sky ATP has, as Your Honor pointed out,
`
`infringing and noninfringing functionality. Some of the
`
`noninfringing functionality involves geo location, various
`
`other things we would never accuse of infringing. Even the
`
`antivirus lookup is noninfringing. But what is infringing is
`
`when they get to the static scanning and the dynamic scanning.
`
`So we have Mr. Icasiano, who ran a special report that
`
`says -- he had a gentleman by the name of Curan to run a report
`
`to obtain the number -- 40 percent of new samples submitted by
`
`the customers are sent to dynamic analysis. This was limited
`
`to the time period of January 2017 and before, the infringing
`
`time period.
`
`THE COURT: So what would that prove?
`
`MR. ANDRE: That's your apportionment. That's the
`
`infringing footprint. 40 percent of the scans done by Sky ATP
`
`is infringing.
`
`THE COURT: Well, let me give you a hypothetical.
`
`Let's say that every single message that comes through the
`
`router goes through Sky ATP. Your theory would then be a
`
`hundred percent.
`
`MR. ANDRE: No.
`
`THE COURT: Why not?
`
`MR. ANDRE: Because when a -- it's not going through
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 15 of 218
`
`PROCEEDINGS
`
` 629
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`the -- and I'll correct Counsel. It's not a router. It's a
`
`firewall. The SRX is a firewall. They have other routers out
`
`there in the system.
`
`SRX is a firewall that when a file comes to SRX, if it's
`
`passed to Sky ATP, only 40 percent of those that are passed to
`
`Sky ATP are infringing. That's what we're saying. That's the
`
`apportionment.
`
`We've taken it down to the exact incremental value, or
`
`footprint of the invention it's called sometimes, of
`
`40 percent.
`
`THE COURT: I'm still not getting it. I want to -- I
`
`want you to -- so let's say that -- just take a number. Let's
`
`say that there are a thousand packets that reach the SRX. On
`
`the data that you have, what percentage of those get sent to
`
`Sky ATP?
`
`MR. ANDRE: Some of them go right through the SRX and
`
`never go to Sky ATP.
`
`THE COURT: I know. So what percentage -- what is
`
`what?
`
`MR. ANDRE: If it goes through and determines it has
`
`not seen it through its antivirus, that's not an apportionment
`
`we're looking at. We're looking at the infringing
`
`functionality --
`
`THE COURT: No, no, no, no. Maybe I don't even
`
`understand how it works, but I think I do.
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 16 of 218
`
`PROCEEDINGS
`
` 630
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`When a packet comes from the Internet to the SRX -- and
`
`let's assume it's a firewall for a moment -- does every single
`
`packet go up to Sky ATP?
`
`MR. ANDRE: I don't think so, no.
`
`THE COURT: Well, what percentage do?
`
`MR. ANDRE: We don't know that. They don't track
`
`that.
`
`THE COURT: Well, that's -- isn't that your burden?
`
`MR. ANDRE: No, Your Honor. That's not our
`
`apportionment.
`
`We have an infringement theory of Sky ATP by itself, as
`
`you know, without SRX. And we have Sky ATP with SRX. And so
`
`if you look at just the Sky ATP functionality -- that's what
`
`we're focusing on here, the Sky ATP by itself -- then every
`
`file that comes into Sky ATP, into that ecosystem, 40 percent
`
`of them will go through that infringing system that we have on
`
`Claim 10. So we have an exact apportionment of Sky ATP.
`
`Your Honor mentioned the Blue Coat case. And I said I
`
`argued that case. What we said there was very similar. Went
`
`up to the cloud, and we said there -- instead of Sky ATP, it
`
`was DRTR. And we said everything that gets into DRTR, a
`
`hundred percent of it would be infringing.
`
`And the Federal Circuit said no, DRTR does other things.
`
`You had to say which percentage went through the scanning. And
`
`we didn't do that.
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 17 of 218
`
`PROCEEDINGS
`
` 631
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`So now we've done it this time with Sky ATP. We're
`
`telling this court what percentage of those packets that are
`
`coming in are going through the scanning of dynamic scanning.
`
`That's the last in the chain.
`
`That's the reason we put that information up there about
`
`starts off caching, antivirus, static, and then dynamic.
`
`So dynamic is the last step in the chain. So when it gets
`
`to dynamic, we know it's going through the infringing system.
`
`THE COURT: How do we know that?
`
`MR. ANDRE: Because that was the evidence we have in,
`
`in the case, Dr. Cole.
`
`THE COURT: I have a very related point. Claim 1 does
`
`not infringe. It's invalid. And are you including things in
`
`there that would violate Claim 1?
`
`In other words, to my mind, it ought to be just those --
`
`the difference between Claim 1 and Claim 10 is the data manager
`
`and the scanner, I guess. Is that it?
`
`By the way, I do want you to know, it never ceases to
`
`amaze me what gets through the Patent Office. In light of what
`
`was already known in the art here, that this could have gotten
`
`through the Patent Office. It's a very thin case for validity.
`
`I'm not saying it's invalid. Not yet. I might
`
`eventually. But I'm telling you this -- but you've got to
`
`apportion to the little thin sliver -- the thin sliver of an
`
`idea of an invention here is where you've got to apportion to.
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 18 of 218
`
`PROCEEDINGS
`
` 632
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`You can't apportion to something that's only covered by
`
`Claim 1.
`
`MR. ANDRE: And, Your Honor, we're not. We're
`
`actually going through the system of Claim 10.
`
`Just for some context, last Thursday, before this trial
`
`started, I was in D.C. arguing to the Federal Circuit on
`
`Claim 1 and Claim 10. The Claim 10 has been through -- claimed
`
`three IPRs.
`
`We've had Palo Alto Networks, Symantec, Blue Coat,
`
`everyone under the sun challenging the validity of this patent.
`
`The IPR process is a very vigorous process, and they are
`
`slanted in favor of the petitioner, against the patent owners,
`
`as you're probably well aware of.
`
`This claim has been held valid time and time again.
`
`THE COURT: Well, how many times? My law clerk told
`
`me just once.
`
`MR. ANDRE: Three times.
`
`THE COURT: Three times.
`
`MR. ANDRE: And we just argued for the Federal Circuit
`
`the one where we won on that. So we actually have three
`
`different IPRs, two of them being consolidated, where Claim 10
`
`has been found valid in two final written decisions; one
`
`noninstitution.
`
`So my point is --
`
`THE COURT: Maybe a district judge is going to
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 19 of 218
`
`PROCEEDINGS
`
` 633
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`disagree. Maybe not. I don't know. I'm not going to reach
`
`that yet.
`
`But I will say this, I know enough about this area to say
`
`this is a very minuscule improvement over the art, if there is
`
`one. And so it may have scraped by, by the skin of its teeth,
`
`as valid, but I don't -- I think you've got to somehow subtract
`
`out of it the stuff that's covered only by Claim 1.
`
`Have you done that?
`
`MR. ANDRE: Your Honor, Claim 10 is a system claim.
`
`We've gone through and shown what part of the system -- what
`
`part of files go through the system. This is not a small
`
`improvement over the system. It was revolutionary at the time.
`
`At the time it was.
`
`THE COURT: Please. Come on.
`
`MR. ANDRE: Your Honor, back in 1996, that's what the
`
`Federal Circuit said.
`
`THE COURT: I want to tell you a few things. Everyone
`
`knows, who's done any coding, that if you go through a lot of
`
`trouble to derive a number and there's even a small chance
`
`you're ever going to need it again, you ought to save it rather
`
`than require the computer to go through that stuff again. And
`
`if you're going to save it, you need a data manager to be able
`
`to recall it. Could be a simple thing.
`
`You, yourself, said if there's a data manager, there's
`
`going to be data. Well, it works the other way too. If
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 20 of 218
`
`PROCEEDINGS
`
` 634
`
`there's going to be data, there's going to be a data manager.
`
`MR. ANDRE: What the Federal Circuit has found to be
`
`pioneering, and that was --
`
`THE COURT: Is that their term?
`
`MR. ANDRE: Their words.
`
`THE COURT: The Federal Circuit said this thing was
`
`pioneering?
`
`MR. ANDRE: They said what was pioneering was the way
`
`the --
`
`THE COURT: They said Claim 10 was pioneering?
`
`MR. ANDRE: They said the technology relating back to
`
`these patents -- Claim 10 hasn't got through to that process
`
`yet. I argued that Thursday.
`
`The related patent had the downloadable security profile,
`
`the DSP, same thing as this one, a related patent. They said
`
`the way that Finjan came up with a system to generate profiles,
`
`the scanning they did on antivirus was pioneering. That's
`
`their words. That's the Federal Circuit.
`
`So going back to 1996 --
`
`THE COURT: Scanning is not the patent here. The
`
`claim-in-suit is -- it has scanning as part of it, but the
`
`particular method for scanning is not claimed.
`
`MR. ANDRE: It is generating -- it is scanning and
`
`generating a downloadable security profile that contains a list
`
`of suspicious operations. That is common in probably eight to
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 21 of 218
`
`PROCEEDINGS
`
` 635
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`ten of Finjan patents, that claim language. That concept --
`
`THE COURT: It's known in the art to go through and
`
`get all those codewords.
`
`MR. ANDRE: It was not. Not in 1996. That's the
`
`reason that we've survived numerous IPRs.
`
`Finjan's patent portfolio had almost a hundred IPRs filed
`
`against it. I think we've lost three claims so far, and
`
`they're still on appeal.
`
`This technology in 1996 was a paradigm shift. We have
`
`publications that said it was -- they invented behavior-based
`
`scanning. Now, before this, it was antivirus, it was
`
`signature-based scanning.
`
`THE COURT: You told me yourself, earlier, that the
`
`sandbox idea was in the prior art.
`
`MR. ANDRE: I didn't say that.
`
`THE COURT: Was it? You're saying that Finjan
`
`invented the sandbox idea?
`
`MR. ANDRE: The idea of generating a downloadable
`
`security profile with a list of suspicious operations was
`
`invented by Finjan. That has been determined by numerous
`
`courts, Patent Office, and the Federal Circuit.
`
`We've had the '494 patent challenge on invalidity in this
`
`district, from other judges, with juries. We've come out
`
`alive. We've had posttrial motions. We've had IPRs. We've
`
`had, now, a Federal Circuit argument last Thursday.
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 22 of 218
`
`PROCEEDINGS
`
` 636
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`So I know your Honor may think that in hindsight it looks
`
`not that great --
`
`THE COURT: Well, no, it looks pretty good until you
`
`realize how much of it was in the prior art. And then you've
`
`got to ask, was it obvious over what was in the prior art? And
`
`I'm telling you that I -- I don't know. I'd have to hear more
`
`testimony, I think.
`
`But this is -- but your guy got on the stand, Mr. Cole,
`
`and he told the jury that -- and there were three things.
`
`Ms. Carson did a good job on this. Everything that he said
`
`was -- the best thing since sliced bread was in Claim 1.
`
`Everything. And that's all he focused on. It was so
`
`misleading. I really feel like you tried to deceive the jury
`
`on this.
`
`All right. Here's my point: I'm going to listen to what
`
`you have to say about apportionment, but I want you to be ready
`
`to possibly -- as soon as the plaintiff's case is over, we'll
`
`hear the Rule 50 on damages.
`
`I may have to excuse the jury. And there's a chance --
`
`I'm not going to say what -- maybe -- that we will exclude
`
`damages. If I do that, then I'm going to take away some of
`
`your time. If you're going to object to that, I'm going to
`
`make -- we're just going to hear everything.
`
`But there's no way that it would be fair for you -- if
`
`we're going to take damages away on Rule 50, that you get all
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 23 of 218
`
`PROCEEDINGS
`
` 637
`
`that extra time.
`
`So you need to be able to tell me in a few minutes, before
`
`I get into it, how much time you would give up. It would have
`
`to be enough to make it worthwhile so that we would have a
`
`fighting chance to end this case tomorrow.
`
`I think the apportionment problem is severe here. It's
`
`total greed, and it's an unwillingness to try to focus in on
`
`what is the real invention here.
`
`Now, you say it's a firewall.
`
`You say it's a router.
`
`MR. KAGAN: Your Honor, it is a -- it is a firewall,
`
`but it has routing functions as well. The name SRX stands for
`
`security, which is the firewall; R, router; and X, switch. It
`
`all has functions built into one box.
`
`THE COURT: Well, is that part of the record here?
`
`MR. KAGAN: Yes, Your Honor, it is.
`
`THE COURT: All right. I mean part of the record
`
`before the jury.
`
`MR. KAGAN: It will be when Mr. Bushong testifies
`
`later today.
`
`THE COURT: Well, but I can't take that into account
`
`when I'm evaluating just the plaintiff's case.
`
`MR. KAGAN: Your Honor, it is irrelevant for the
`
`apportionment what you call the device. In other words, what
`
`is -- what is clear is that it has mixed functionality.
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 24 of 218
`
`PROCEEDINGS
`
` 638
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`MS. CARSON: And Trial Exhibit 345 actually contains
`
`the functionality for the SRX. So it is part of the record
`
`even though there hasn't been testimony on it. It's the sheet
`
`for the SRX that shows all of the various functionality.
`
`THE COURT: When we get to it, there are two levels of
`
`apportionment that I am concerned about. One is the hardware.
`
`And the hardware does have several functions, because -- here's
`
`the simple way in which I'm looking at this. But before this
`
`product ever got introduced, Juniper had long been in the
`
`business of developing boxes that looked a lot like this and
`
`did a lot of the same things.
`
`But this box now has the additional protection against
`
`malware, but it's still doing those earlier functions. There's
`
`got to be some credit given for the fact that the -- some
`
`apportionment for the fact that the box continues to do those
`
`earlier functions. Now, I don't see where that's being taken
`
`into account here, but maybe.
`
`Second is that even for those files that get sent to the
`
`Sky ATP, there are aspects of the Sky ATP that are unpatented
`
`and there are aspects that are patented. And is that level
`
`being apportioned?
`
`You don't have an expert anymore. So I don't know how
`
`you -- you know, you're going to have to show me -- the reason
`
`you don't have an expert is you swung for the fences. And
`
`you -- you didn't bother to do any of this before.
`
`
`
`Case 3:17-cv-05659-WHA Document 338 Filed 12/17/18 Page 25 of 218
`
`PROCEEDINGS
`
` 639
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`This is what's on my mind. And I'm giving you this
`
`heads-up because it may go pretty fast. It could be motion
`
`granted, case truncated, case goes to the jury.
`
`Now, there's another thing I want to put you on notice of.
`
`There's some chance, not as big a chance, that at the end of
`
`your case I would grant a Rule 50 in your favor on
`
`infringement, on the plaintiff's side, because, as I say all
`
`this, I'm not too impressed with the defense on the issue of
`
`infringement. But maybe I'm wrong.
`
`Maybe when your expert gets up there I will -- and I have
`
`to remember it's for the jury to decide, not for me to decide.
`
`So the issue will be,